Home/Filings/4/0001799191-24-000042
4//SEC Filing

Carter Robert Ross 4

Accession 0001799191-24-000042

CIK 0001799191other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 6:21 PM ET

Size

5.4 KB

Accession

0001799191-24-000042

Insider Transaction Report

Form 4
Period: 2024-11-20
Carter Robert Ross
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Class A Common Stock

    2024-11-20$0.14/sh235$3231,759 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
  • [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.136 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Issuer

Oncology Institute, Inc.

CIK 0001799191

Entity typeother

Related Parties

1
  • filerCIK 0002039341

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 6:21 PM ET
Size
5.4 KB